[Federal Register Volume 61, Number 30 (Tuesday, February 13, 1996)]
[Notices]
[Pages 5570-5571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-3170]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on November 17, 1995, Isotec,
Inc., 3858 Benner Road, Miamisburg, Ohio 45342, made application to the
Drug Enforcement Administration (DEA) for registration as
[[Page 5571]]
a bulk manufacturer of the basic classes of controlled substances
listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
Methaqualone (2565)........................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymetham -phetamine (7405). I
4-Methoxyamphetamine (7411)................ I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
N-Ethyl-1-phenylcyclohexylamine (7455)..... I
Codeine (9050)............................. II
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Acetylmethadol (9601)...................... I
Alphacetylmethadol Except Levo- I
Alphacetylmethadol (9603).
Normethadone (9635)........................ I
3-Methylfentanyl (9813).................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
1-Piperidinocyclohexanecarbo -nitrile II
(8603).
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Levo-Alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to use small quantities of the listed controlled
substances to produce standards for analytical laboratories.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than (60 days from publication).
Dated: February 2, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-3170 Filed 2-12-96; 8:45 am]
BILLING CODE 4410-09-M